But majority of U.S. Black women diagnosed with lung cancer still would have been ineligible for screening under 2021 USPSTF guideline
THURSDAY, Dec. 9, 2021 (HealthDay News) — Changes in the 2021 U.S. Preventive Services Task Force (USPSTF) lung cancer screening guidelines increased the proportion of Black women diagnosed with lung cancer who would have been eligible for screening, according to a research letter published online Nov. 24 in JAMA Oncology.
Alexandra L. Potter, from the University of California at Berkeley, and colleagues evaluated lung cancer screening eligibility among U.S. Black women under the 2013 and 2021 USPSTF guidelines. The analysis included 58,973 participants in the Black Women’s Health Study (followed from July 1995 through December 2017) with annual linkages to state cancer registries and the National Death Index.
The researchers found that using the 2013 USPSTF guidelines, 22.7 percent of participants with lung cancer who had a smoking history would have been eligible for lung cancer screening versus 33.9 percent using the new 2021 guidelines, representing a 50 percent increase in eligibility. A total of 314 smokers would not have been eligible for screening under the 2021 guidelines because they had fewer than 20 pack-years of smoking history (67.8 percent) or because they quit smoking more than 15 years ago (46.2 percent). Among ever smokers, sensitivity and specificity of the 2021 guidelines were 33.9 and 86.5 percent, respectively. Sensitivity increased to 48.2 percent when removing the requirement that former smokers must have quit smoking within the past 15 years, while specificity decreased to 78.9 percent.
“Our findings suggest that removing the 15 years since quitting criteria in the current USPSTF guidelines may be beneficial for Black women,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Cancer Risk ID"d for Asian American, NHPI Population
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC
Recommendations Updated for Radiation Therapy in Pancreatic Cancer
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer